Results 21 to 30 of about 1,127,554 (354)

Organoids from patient biopsy samples can predict the response of BC patients to neoadjuvant chemotherapy

Annals of Medicine, 2022
Propose Neoadjuvant chemotherapy has been widely used in locally advanced and inflammatory breast cancer. Generally, complete pathological response after neoadjuvant chemotherapy treatment predicts survival.
Dan Shu, Meiying Shen, Kang Li, Xiaojian Han, Han Li, Zhaofu Tan, Yu Wang, Yang Peng, Zhenrong Tang, Chi Qu, Aishun Jin, Shengchun Liu   +11 more
doaj   +1 more source

Breast cancer: Monitoring response to neoadjuvant chemotherapy using Tc-99m sestamibi scintimammography [PDF]

, 2003
Background: Aim of the study was to assess the value of scintimammography using Tc-99m sestamibi in the evaluation of tumor response to neoadjuvant chemotherapy.
Brinkbäumer, K., Hahn, K., Keßler, M., Linke, R., Sommer, H., Tiling, R., Untch, M.   +6 more
core   +1 more source

Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non–Small-Cell Lung Cancer (NADIM phase II trial)

Journal of Clinical Oncology, 2022
PURPOSE Neoadjuvant chemotherapy plus nivolumab has been shown to be effective in resectable non–small-cell lung cancer (NSCLC) in the NADIM trial (ClinicalTrials.gov identifier: NCT03081689).
M. Provencio, R. Serna-Blasco, E. Nadal, A. Insa, M. García-Campelo, J. Casal Rubio, M. Dómine, M. Majem, D. Rodríguez-Abreu, A. Martínez-Martí, J. de Castro Carpeño, M. Cobo, G. López Vivanco, E. del Barco, R. Bernabé Caro, N. Viñolas, I. Barneto Aranda, S. Viteri, E. Pereira, A. Royuela, V. Calvo, Javier M. Martín-López, F. García-García, M. Casarrubios, Fernando Franco, E. Sánchez-Herrero, B. Massutí, A. Cruz-Bermúdez, A. Romero   +28 more
semanticscholar   +1 more source

Current Oncological Treatment of Patients with Pancreatic Cancer in Germany: Results from a National Survey on behalf of the Arbeitsgemeinschaft Internistische Onkologie and the Chirurgische Arbeitsgemeinschaft Onkologie of the Germany Cancer Society [PDF]

, 2009
Background: No data have previously been available regarding the current treatment of patients with pancreatic cancer (PC) in German hospitals and medical practices.
Boeck, Stefan, Bruns, Christiane J., Heinemann, Volker, Jauch, Karl-Walter, Sargent, Mirja, Schäfer, Claus, Seufferlein, Thomas   +6 more
core   +1 more source

Neoadjuvant endocrine therapy for luminal breast cancer treatment: a first-choice alternative in times of crisis such as the COVID-19 pandemic [PDF]

, 2020
The epidemiological emergency caused by CoV-2 (COVID-19) has changed priorities in breast cancer management. In those places where the pandemic has had the greatest effect, it is of paramount importance for most patients to be at home, reducing or ...
Martí, Covadonga, Sánchez-Méndez, José I.   +1 more
core   +1 more source

Magnetic resonance imaging tumor regression shrinkage patterns after neoadjuvant chemotherapy in patients with locally advanced breast cancer: correlation with tumor biological subtypes and pathological response after therapy [PDF]

, 2017
The objective of this study is to analyze magnetic resonance imaging shrinkage pattern of tumor regression after neoadjuvant chemotherapy and to evaluate its relationship with biological subtypes and pathological response.
Anastasi, Emanuela, Ballesio, Laura, Catalano, Carlo, DI PASTENA, Francesca, Gigli, Silvia, Giraldi, Guglielmo, Manganaro, Lucia   +6 more
core   +1 more source

Different responses to neoadjuvant chemotherapy in urothelial carcinoma molecular subtypes

medRxiv, 2021
For muscle-invasive bladder cancer (MIBC), there are no tissue biomarkers in clinical use that identify patients sensitive or resistant to neoadjuvant chemotherapy.
G. Sjödahl, J. Abrahamsson, K. Holmsten, C. Bernardo, G. Chebil, P. Eriksson, I. Johansson, P. Kollberg, C. Lindh, Kristina Lövgren, N. Marzouka, H. Olsson, M. Höglund, A. Ullén, F. Liedberg   +14 more
semanticscholar   +1 more source

Neoadjuvant chemotherapy for primary sarcoma of the breast: a case report

Journal of Medical Case Reports, 2019
Background Primary sarcoma of the breast is rare. Surgery has been the only curative treatment available. Recently, neoadjuvant chemotherapy including anthracycline/ifosfamide has been reported effective for patients with high-risk sarcomas in a ...
Chieko Miyazaki, Mikio Shiozawa, Rintaro Koike, Kasumi Ogihara, Yumiko Sasaki, Satomi Shiba, Saki Nishida, Masako Sakuragi, Hirofumi Mizunuma, Takashi Fujita, Noriyoshi Fukushima, Alan K. Lefor, Joji Kitayama, Naohiro Sata   +13 more
doaj   +1 more source

CCND1 as a predictive biomarker of neoadjuvant chemotherapy in patients with locally advanced head and neck squamous cell carcinoma. [PDF]

PLoS ONE, 2011
BACKGROUND: Cyclin D1 (CCND1) has been associated with chemotherapy resistance and poor prognosis. In this study, we tested the hypothesis that CCND1 expression determines response and clinical outcomes in locally advanced head and neck squamous cell ...
Zhien Feng, Wei Guo, Chenping Zhang, Qin Xu, Ping Zhang, Jian Sun, Hanguang Zhu, Zhonghe Wang, Jiang Li, Lizhen Wang, Bingshun Wang, Guoxin Ren, Tong Ji, Wenyong Tu, Xihu Yang, Weiliu Qiu, Li Mao, Zhiyuan Zhang, Wantao Chen   +18 more
doaj   +1 more source

An open, observational, three-arm clinical study of 2–3 cycles of treatment as neoadjuvant therapy in operable locally advanced non-small cell lung cancer: An interim analysis

Frontiers in Immunology, 2022
BackgroundAn open, observational, three-arm clinical study aimed at investigating the efficacy of different neoadjuvant therapies (neoadjuvant immunotherapy with(out) chemotherapy, neoadjuvant chemotherapy, and neoadjuvant targeted therapy) in operable ...
Linping Gu, Xue Wang, Yile Sun, Yunhua Xu, Xiaomin Niu, Ruiying Zhao, Yaxian Yao, Hong Jian, Yuchen Han, Jinwang Wei, Zhiwei Chen, Shun Lu   +11 more
doaj   +1 more source